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Abstract
To compare the effect of gonococcal co-infection on immortalized versus primary CD4
+ T cells the Jurkat cell line or freshly
isolated human CD4
+ T cells were infected with the HIV-1 X4 strain NL4-3. These cells were exposed to whole gonococci,
supernatants from gonococcal-infected PBMCs, or N. gonorrhoeae-induced cytokines at varying levels. Supernatants from
gonococcal-infected PBMCs stimulated HIV-1 replication in Jurkat cells while effectively inhibiting HIV-1 replication in
primary CD4
+ T cells. ELISA-based analyses revealed that the gonococcal-induced supernatants contained high levels of
proinflammatory cytokines that promote HIV-1 replication, as well as the HIV-inhibitory IFNa. While all the T cells responded
to the HIV-stimulatory cytokines, albeit to differing degrees, the Jurkat cells were refractory to IFNa. Combined, these results
indicate that N. gonorrhoeae elicits immune-modulating cytokines that both activate and inhibit HIV-production; the
outcome of co-infection depending upon the balance between these opposing signals.
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Introduction
Co-infection between HIV and other sexually transmitted
infections (STIs) is an area of intense interest because of the
impact that STIs have on the global spread of HIV. Clinical and
epidemiological studies have revealed a positive correlation
between STI co-infection and increased genital tract viral
shedding and/or susceptibility to HIV-1 [1–3]. However, the lack
of a non-human in vivo model that accurately reflects what occurs
during co-infection has led to a reliance on in vitro models to study
these interactions. This has yielded conflicting, sometimes
confusing results that affect confidence in the interpretations.
One of the better-studied co-infections is that involving Neisseria
gonorrhoeae and HIV-1. We observed that N. gonorrhoeae can directly
stimulate HIV-1 LTR-mediated transcription from a Jurkat-
derived CD4
+ T cell line [4]. Subsequent work established that
gonococci can also stimulate HIV-1 expression from monocyte-
derived dendritic cells [5] and primary CD4
+ T cells [6] through
stimulation of innate signaling receptors. However, exposure of
mixed PBMCs to whole gonococci [7] or treatment of purified
primary macrophages with gonococcal lipooligosaccharide [8]
inhibits HIV-1 replication through Type I interferon production.
While the ultimate effect of N. gonorrhoeae on HIV-1 replication in
vivo will depend upon the cumulative effect of activating and
inhibitory stimuli, these conflicting observations have made it
difficult to dissect the impact of N. gonorrhoeae infection on viral
expression at a cellular level.
The use of immortalized cell lines, be they epithelial or CD4
+ T
cell lines, has been widely used to understand both the biology of
the HIV-1 life cycle and in drug discovery due to the ease of cell
line manipulation. While they may be a powerful resource for
certain applications, we sought to compare their suitability for N.
gonorrhoeae-HIV co-infection studies. We observed striking differ-
ences between HIV-1-infected Jurkat CD4
+ T cells and primary
human CD4
+ T cells related to innate responses to the bacteria.
Results
Contrasting responses from Jurkat or primary CD4
+ T
cells exposed to N. gonorrhoeae
Jurkat CD4
+ T cells are a workhorse for studying CD4
+ T cell
biology, including studies with HIV-1. Consistent with our past
observations using a Jurkat-derived HIV-LTR-driven reporter cell
line [4], Jurkat co-infection with replication-competent HIV-1 X4
strain NL4-3 and N. gonorrhoeae promotes HIV-1 expression and
replication (Fig 1A and C). However, when we began examining
primary CD4
+ T cells HIV-1 replication very little p24 was
apparent from unstimulated primary CD4
+ T cells, consistent with
the published need for T cell activation to drive HIV-1 expression
in non-immortalized T cells [9]. This necessitated using T cell
receptor and CD28 antibodies stimulation to detect substantial
amounts of HIV-1. In this system, the HIV-stimulatory effect of N.
gonorrhoeae was less apparent in the co-infected primary CD4
+ T
cells at the tested multiplicity of infection (MOI) of 10 bacteria per
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and D).
We have recently established that N. gonorrhoeae elicits a potent
plasmacytoid dendritic cell response in mixed primary PBMC
cultures, leading to their production of sufficient IFNa to inhibit
HIV-1 replication [7]. Unexpectedly, supernatants recovered from
gonococcal-infected PBMCs strongly stimulated HIV-1 replication
in Jurkat T cells (Fig 2A and C) yet, as previously reported [7], still
potently inhibited HIV-1 replication in the primary activated
CD4
+ T cell system (Fig 2B and D).
Differential response of Jurkat and primary human CD4
+
T cells to N. gonorrhoeae-elicited cytokines that control
HIV-1 expression
To understand why supernatants from gonococcal-infected
PBMCs elicited significantly different effects on HIV-1 replication
than didexposure to the bacteria alone, we analyzed the supernatants
for asubsetofcytokineswiththepotentialto affect HIV-1replication.
Along with inhibitory IFNa, the gonococcal-infected supernatants
contained substantially increased levels of TNFa,I L - 1 b and IL-6
(Fig 3A–D) but no significant differences in IL-8 or IL-17 (data not
shown). Treatment of the T cells with one of the pro-inflammatory
cytokines elicited by N. gonorrhoeae infection, TNFa, stimulated HIV
replication in Jurkat cells and less so in primary CD4
+ T cells under
the conditions used (Fig 4A). Since a variety of proinflammatory
cytokines, including IL–1b and IL-6, can each promote HIV
expression [10–13], the gonococcal-induced stimulatory effect will
result from a convergence of these activating signals. The
proinflammatory cytokines secreted in response to N. gonorrhoeae are,
therefore, sufficient to stimulate HIV-1 expression in CD4
+ T cells.
Relative sensitivities of Jurkat and primary T cells to IFNa
explains their differential response to N. gonorrhoeae
While gonococcal induction of pro-inflammatory cytokines may
be responsible for the increase in HIV-1 expression seen in
gonococcal supernatant exposed Jurkat T cells, it does not explain
the disparity in viral expression levels between primary and
immortalizedcells.WehavepreviouslyestablishedthatN.gonorrhoeae
Figure 1. N. gonorrhoeae stimulates HIV-1 replication in CD4
+ T cells. HIV-1-infected Jurkat CD4
+ T cells (A and C) or T cell receptor
crosslinking antibody-activated primary CD4
+ T cells (B and D) were co-infected with N. gonorrhoeae at a MOI of 10 (Infected) or left infected with HIV-
1 alone (Uninfected) for 5 or 7 days respectively. Subsequently the level of HIV-1 replication was quantified by ELISA for p24 antigen. (A) and (B)
represent the mean6s.d. of the actual p24 antigen levels of triplicate wells of one representative experiment. Due to the difficulty in replicating exact
HIV-1 infection levels experiment to experiment, (C) and (D) represent the mean6s.e.m. of a minimum of 3 separate experiments with the amount of
HIV-1 replication expressed as the percentage of p24 antigen found in bacterial-uninfected samples to allow statistical measurements to be
performed. Significant differences are represented by comparison with the following legend: *p#0.05.
doi:10.1371/journal.pone.0018133.g001
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and used cytokine-specific antibody blocking experiments to
demonstrate that IFNa was responsible for the HIV-inhibitory
effect of N. gonorrhoeae-infected PBMC supernatants [7]. This
prompted us to compare the relative effect of purified IFNa on
Jurkat T cells and primary CD4
+ T cells. As illustrated in Fig 4B,
Jurkats were highly refractory to the effects of purified IFNa when
compared to primary CD4
+ T cells, including significant differences
at concentrations of IFNa reflecting that induced by N. gonorrhoeae
infection (50 U/ml, denoted with a box in Fig 4B).
Discussion
Many studies concerning the effect of co-infecting pathogens or
other agents on the HIV-1 life cycle have focused on single cell
purified systems using either cell lines or primary cells. However, it
is important to consider that HIV infection, even when focusing
on CD4
+ T cells, never happens in isolation in vivo. Therefore, it is
critical to understand the contribution of other cell types and their
activities, including the production of immune modulators, on the
final response. The host cell’s ability to respond to these diverse
signals is clearly important, yet may not be evident when using
immortalized cell lines due to the various mutations or altered
signaling pathways involved in the immortalization process. In an
effort to separate the direct and indirect effects of N. gonorrhoeae on
HIV-1 expression [4,7,7], we have established co-infection
protocols using both primary leukocytes, either in the form of
peripheral blood mononuclear cells (PBMCs) or isolated CD4
+ T
cells, and with immortalized Jurkat CD4
+ T cells, the most widely
used cell line in T cell research. During these studies, we noted
apparent differences in the viral response to N. gonorrhoeae. Herein,
we directly compared the effect of N. gonorrhoeae on HIV-1
Figure 2. Supernatants from gonococcal-infected PBMCs have opposite effects on immortalized and primary HIV-infected CD4
+ T
cells. HIV-1-infected Jurkat CD4
+ T cells (A and C) or T cell receptor crosslinking antibody-activated primary CD4
+ T cells (B and D) were exposed to
culture supernatants from gonococci-infected (but HIV-uninfected) PBMCs that had been infected with N. gonorrhoeae at a MOI of 10 (Infected
supernatant) or left uninfected (Uninfected supernatant) for 5 or 7 days, respectively. Subsequently, the level of HIV-1 replication was quantifiedb y
ELISA for p24 antigen. (A) and (B) represent the mean6s.d. of the actual p24 antigen levels of triplicate wells from one representative experiment.
Due to the difficulty in replicating exact HIV-1 infection levels experiment to experiment, (C) and (D) represent the mean6s.e.m. of a minimum of 3
separate experiments with the amount of HIV-1 replication expressed as the percentage of p24 antigen found in uninfected supernatant exposed
samples to allow statistical measurements to be performed. Significant differences are represented by comparison with the following legend:
*p#0.05, ***p#0.001.
doi:10.1371/journal.pone.0018133.g002
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+ T cells and the immortalized
Jurkat human CD4
+ T cell line. We observed that the gonococci
had a direct stimulatory effect on both cell types, however the
amplitude of this effect was substantially greater in Jurkat cells
than in the primary CD4
+ T cells. Strikingly, however, culture
supernatants from N. gonorrhoeae-infected PBMCs had opposite
effects on these two cell types, potently stimulating HIV-1
expression from Jurkat cells while effectively blocking HIV-1
expression from primary CD4
+ T cells.
Since gonococcal infection has been naturally associated with a
strong inflammatory response [14], we monitored representative
cytokines with the potential to effect HIV replication in an effort to
explain these opposing effects. We observed that N. gonorrhoeae-
infected PBMCs expressed very high levels of TNFa, IL-6 and IL-
1b each of which have previously been shown to stimulate HIV-1
replication [10–13]. The convergence of effects from these, and
presumably other, proinflammatory cytokines explain the indirect
stimulatory effect of N. gonorrhoeae-infected PBMC supernatants on
HIV replication in the Jurkat T cells. Since proinflammatory
cytokines can also stimulate HIV-1 expression in primary CD4
+ T
cells, we considered that the differential response of these primary
and immortalized cells might occur due to their different response
to an inhibitory factor. IFNa has a potent antiviral effect and is
secreted by plasmacytoid dendritic cells upon exposure to N.
gonorrhoeae, accumulating in sufficient quantities so as to effectively
block HIV-1 expression in primary CD4
+ T cells [7]. Herein, we
observed that purified IFNa inhibited HIV-1 expression in a dose-
dependent manner in primary CD4
+ T cells, but had little effect
on HIV-infected Jurkat T cells.
Taken together our observations suggest that the Jurkat T cell
line is more sensitive to HIV-1 stimulatory cytokines, such as
proinflammatory cytokines, while less sensitive to HIV-1 inhibitory
IFNa than primary CD4
+ T cells. Such a differential effect must
be considered whenever an immortalized cell line is used as a
model since tumor cells often develop resistance to the death-
inducing effects of Type I interferons [15–18]. Indeed, Jurkat
CD4
+ T cells do not undergo they typical cell cycle arrest or
apoptotic response generally associated with IFNa treatment [19],
consistent with the altered IFNa response described herein. This
important difference suggests caution in extrapolating results
obtained in purified or immortalized cells to the more complex
system of mixed cell types seen in vivo, since the response of other
cell types may combine to obscure direct effects on the co-infecting
virus. However, it also highlights the utility of considering more
than one cell system in order to separate these contrasting effects
to specifically explore their relative inhibitory or stimulatory effects
in isolation.
Materials and Methods
Human primary donors
Informed written consent was obtained from healthy volunteer
blood donors in accordance with the guidelines for conduct of
clinical research at the University of Toronto and St. Michael’s
Figure 3. Supernatants from gonococcal-infected PBMCs
contain both HIV-1 replication stimulating proinflammatory
cytokines and HIV-1 replication inhibiting IFNa. HIV-1-negative
PBMCs were infected with N. gonorrhoeae at a MOI of 10 for 24 hours
and the levels of TNFa (A), IL-6 (B), IL-1b (C) or IFNa (D) were quantified
by ELISA. (A–D) represent the mean6s.e.m. of the cytokine level from
the supernatants from 6 separate PBMC donors. Significant differences
are represented by comparison with the following legend: *p#0.05,
**p#0.01.
doi:10.1371/journal.pone.0018133.g003
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were approved by the University of Toronto and St. Michael’s
Hospital institutional review boards.
Cell preparation
Peripheral blood mononuclear cells (PBMCs) were isolated by
leukopheresis (Spectra apheresis system; Gambro BCT) from the
volunteers. Buffy coats were collected using Ficoll-Paque Plus
(Amersham Biosciences) following the manufacturer’s instructions,
and frozen at 280uC in 90% (vol/vol) heat-inactivated fetal calf
serum (FCS) (HyClone) and 10% (vol/vol) dimethyl sulfoxide
(DMSO) (Sigma-Aldrich) for subsequent experimentation. When
needed, PBMCs were thawed and negatively-selected to isolate
CD4
+ T lymphocytes using the EasySep immunomagnetic-based
cell purification system (StemCell Technologies) according to the
manufacturer’s instructions, achieving purification levels of 92–
95%. Jurkat, clone E6-1 (ATCC – #TIB 152), was also used in
this study. T cell cultures were routinely monitored by Trypan
Blue exclusion, and confirmed that gonococcal infection did not
decrease the viability of T cell cultures.
HIV-1 p24 antigen ELISAs
The levels of HIV-1 present in culture supernatants were
quantified by ELISA for p24 antigen using high sensitivity kits
purchased from ZeptoMetrix Corporation when the levels of p24
were within the range of 7.8–313 pg/ml or from Biological
Products Laboratory (Frederick Cancer and Research Develop-
ment Centre) when the levels of p24 were above 313 pg/ml. All
ELISAs were performed according to manufacturer directions.
ELISA plates were read at 450 nm on a VersaMax microplate
reader using Softmax Pro 5.0 software (Molecular Devices).
Replication competent HIV-1 virus generation, titering
and infection
HIV-1 X4 virus NL4-3 was generated in 293T cells [20] grown
in complete DMEM (10% heat-inactivated fetal calf serum (FCS),
1% GlutaMax-1; Gibco-Invitrogen). HIV-1 X4 virus was used in
this study since the Jurkat T cells, similar to most CD4
+ T cell
lines, do not endogenously express high levels of CCR5 to support
R5 virus replication [21]. U87-CD4-CXCR4 (obtained through
the NIH AIDS Research and Reference Reagent Program
[RRRP], Division of AIDS, NIAID, NIH) was also grown in
complete DMEM with additional selection (1 mg/ml puromycin
(Sigma-Aldrich) and 300 mg/ml geneticin (Bioshop Canada Inc.)).
293T cells were transfected with pNL4-3 (obtained through the
AIDS-RRRP) using Fugene 6 (Roche, Indianapolis, IN) according
to manufacturer’s instructions. 48 hours post-transfection, NL4-3
virus was isolated, clarified by centrifugation at 450 g for 10
minutes, filtered through a 0.45 mm filter and applied to U87-
CD4-CXCR4 in the absence of selection to further amplify virus.
At peak levels of virus replication, as determined by ELISA for
HIV-1 p24 antigen, virus was harvested, filtered and stored in
aliquots at 280uC. Viral titering was performed as described
previously [7].
Primary purified CD4
+ T lymphocytes or Jurkat T cells
were infected with a multiplicity of infection (MOI) of
0.001 TCID
50/ml of HIV-1 NL4-3 in a total volume of 100 ml
complete RPMI-1640/10
6 cells at room temperature for 2 hours
using spinoculation at 1800 g. Subsequently, cells were washed
with cold RPMI-1640 medium containing 2% FCS 3 times and
resuspended to a concentration of 2610
6 cells/ml in complete
RPMI-1640 alone (Jurkat cells) or containing 10 U/ml IL-2 (BD
Biosciences; primary cells) in preparation for bacterial infection.
10 ng/ml TNFa (BD Biosciences) or immobilized anti-human
CD3 and CD28 antibodies (BD Biosciences) were used as positive
controls to stimulate viral replication. Purified IFNa (PBL
Biomedical Laboratories) was used across the range of 5–
5000 U/ml, with addition at the time of viral infection, and
replaced whenever media changes were performed.
Gonococcal strain, bacterial co-infection and ‘inhibitory’
supernatant generation
The Neisseria gonorrhoeae MS11-derived strain N302 was gener-
ously provided by Prof. T.F. Meyer (Berlin). Culture, infection and
Figure 4. TNFa and IFNa affect HIV-1 replication in Jurkat and primary CD4
+ T cells respond differently to HIV-1 stimulatory or
inhibitory cytokines. HIV-1-infected Jurkat CD4
+ T cells or primary CD4
+ T cells were exposed to TNFa or T cell receptor crosslinking antibodies (A)
or increasing concentrations of IFNa (B) or left untreated for 5 or 7 days respectively. Subsequently, the level of HIV-1 replication was quantified by
ELISA for p24 antigen. Data represent the mean6s.e.m. of a minimum of 3 separate experiments with the amount of HIV-1 replication expressed as
the percentage of p24 antigen compared to unstimulated/untreated samples. Significant differences are represented by comparison with the
following legend: *p#0.05, **p#0.01.
doi:10.1371/journal.pone.0018133.g004
Differing Effects with HIV/Gonorrhea Co-Infection
PLoS ONE | www.plosone.org 5 April 2011 | Volume 6 | Issue 4 | e18133co-infection protocols were performed as described previously [7].
Bacterial infections were carried out with an MOI of 10 bacteria/
cell. Co-infected Jurkat and primary CD4
+ T lymphocyte cultures
were maintained for 5 days or 7 days, respectively, with K media
change occurring 3 days post-infection. Gonococcal infections did
not have an evident effect on the viability of the T cell cultures (data
not shown). Levels of IFNa (PBL Biomedical Laboratories), IL-6,
TNFa or IL-1b (R&D Systems) in the medium were quantified by
ELISA after 24 hours of gonococcal infection.
Statistical analysis
All representative experiments are presented as the mean6standard
deviation (s.d.). All compiled/relative data is presented as the
mean6the standard error (SE) of a minimum of 3 independent
experiments. Statistical significance comparisons between two
compiled samples were calculated using the paired two-tailed
Student’s t test. Statistical significance comparisons between
multiple samples were calculated using a 1-way ANOVA using
the Dunnett’s post-test. All significance calculations were performed
in Prism 5.0 software (GraphPad). Significant differences are
represented by comparison with the following legend: *p#0.05,
**p#0.01, ***p#0.001.
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